Skip to main content
OpenTrials

Clinical trial condition

Immune Thrombocytopenia

Explore clinical trials studying Immune Thrombocytopenia. Study availability and eligibility vary by location and protocol.

94 public trials 33 recruiting studies
Refine in advanced search Browse all conditions

Immune Thrombocytopenia trial results

Completed

Safety and Treatment Satisfaction in Adults With Chronic ITP After Switching to Avatrombopag From Eltrombopag or Romiplostim

NCT04638829

Conditions
Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +16 more
Locations
  • Sobi Site 110 Tucson, Arizona, United States
  • Sobi Site 119 Whittier, California, United States
  • Sobi Site 123 Washington D.C., District of Columbia, United States
  • Sobi Site 129 Miami, Florida, United States
View all 20 locations
View Trial Details
Completed

Study of Oral SKI-O-703, SYK Inhibitor, in Patients With Persistent and Chronic Immune Thrombocytopenia (ITP)

NCT04056195

Conditions
Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +16 more
Locations
  • University of Southern California, 1441 Eastlake Ave. Los Angeles, California, United States
  • Duke University Medical Center, 2301 Erwin Road Durham, North Carolina, United States
  • East Carolina University, 600 Moye Boulevard Greenville, North Carolina, United States
  • The Cleveland Clinic Foundation, 9500 Euclid Avenue Cleveland, Ohio, United States
View all 27 locations
View Trial Details
Completed

Association of Platelet Parameters With Bleeding Severity in Children With ITP

NCT03810352

Conditions
Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +16 more
Locations
  • Children's Hospital Colorado Aurora, Colorado, United States
  • Boston Children's Hospital Boston, Massachusetts, United States
  • Columbia University Medical Center New York, United States
  • Duke University Medical Center Durham, North Carolina, United States
View Trial Details
Completed

A Clinical Study to Evaluate the Efficacy and Safety of LIV-GAMMA SN Inj.10% in Primary Immune Thrombocytopenia (ITP)

NCT05566990

Conditions
Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +16 more
Locations
  • Dong-A University Hospital Busan, South Korea
  • Kosin University Gospel Hospital Busan, South Korea
  • Pusan National University Hospital Busan, South Korea
  • Kyungpook National University Hospital Daegu, South Korea
View Trial Details
Completed

Long-term Study of Romiplostim in Thrombocytopenic Pediatric Patients With Immune Thrombocytopenia (ITP)

NCT02279173

Conditions
Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +16 more
Locations
  • Research Site Roseville, California, United States
  • Research Site Atlanta, Georgia, United States
  • Research Site Chicago, Illinois, United States
  • Research Site Peoria, Illinois, United States
View all 78 locations
View Trial Details

Related conditions